Capital Investment Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $11.1M | Buy |
31,596
+732
| +2% | +$261K | 0.16% | 110 |
|
|
2025
Q4 | $10.1M | Sell |
30,864
-295
| -0.9% | -$93.6K | 0.15% | 117 |
|
|
2025
Q3 | $8.79M | Buy |
31,159
+224
| +0.7% | +$65K | 0.14% | 118 |
|
|
2025
Q2 | $8.64M | Buy |
30,935
+94
| +0.3% | +$26.6K | 0.15% | 114 |
|
|
2025
Q1 | $9.61M | Sell |
30,841
-507
| -2% | -$150K | 0.19% | 104 |
|
|
2024
Q4 | $8.17M | Buy |
31,348
+15
| +0% | +$4.45K | 0.17% | 113 |
|
|
2024
Q3 | $10.1M | Sell |
31,333
-582
| -2% | -$190K | 0.21% | 99 |
|
|
2024
Q2 | $9.97M | Buy |
31,915
+13
| +0% | +$3.82K | 0.23% | 94 |
|
|
2024
Q1 | $9.07M | Sell |
31,902
-431
| -1% | -$126K | 0.21% | 97 |
|
|
2023
Q4 | $9.31M | Sell |
32,333
-591
| -2% | -$161K | 0.23% | 93 |
|
|
2023
Q3 | $8.85M | Buy |
32,924
+474
| +1% | +$118K | 0.24% | 89 |
|
|
2023
Q2 | $7.2M | Buy |
32,450
+3,554
| +12% | +$825K | 0.22% | 91 |
|
|
2023
Q1 | $6.99M | Buy |
28,896
+2,394
| +9% | +$588K | 0.21% | 100 |
|
|
2022
Q4 | $6.96M | Buy |
26,502
+2,700
| +11% | +$724K | 0.21% | 100 |
|
|
2022
Q3 | $5.37M | Buy |
23,802
+255
| +1% | +$61.8K | 0.18% | 109 |
|
|
2022
Q2 | $5.73M | Buy |
23,547
+728
| +3% | +$178K | 0.19% | 104 |
|
|
2022
Q1 | $5.52M | Buy |
22,819
+2,090
| +10% | +$480K | 0.17% | 113 |
|
|
2021
Q4 | $4.66M | Buy |
20,729
+4,544
| +28% | +$959K | 0.14% | 119 |
|
|
2021
Q3 | $3.44M | Buy |
16,185
+904
| +6% | +$208K | 0.12% | 135 |
|
|
2021
Q2 | $3.73M | Buy |
15,281
+29
| +0.2% | +$7.13K | 0.13% | 131 |
|
|
2021
Q1 | $3.79M | Sell |
15,252
-348
| -2% | -$83K | 0.14% | 123 |
|
|
2020
Q4 | $3.59M | Sell |
15,600
-1,484
| -9% | -$342K | 0.15% | 112 |
|
|
2020
Q3 | $4.34M | Sell |
17,084
-49,867
| -74% | -$12.4M | 0.21% | 97 |
|
|
2020
Q2 | $15.8M | Buy |
66,951
+1,350
| +2% | +$308K | 0.82% | 33 |
|
|
2020
Q1 | $13.3M | Buy |
65,601
+805
| +1% | +$176K | 0.85% | 32 |
|
|
2019
Q4 | $15.6M | Buy |
64,796
+269
| +0.4% | +$59.3K | 0.75% | 35 |
|
|
2019
Q3 | $12.5M | Buy |
64,527
+3,863
| +6% | +$741K | 0.65% | 37 |
|
|
2019
Q2 | $11.2M | Buy |
60,664
+34,887
| +135% | +$6.25M | 0.61% | 37 |
|
|
2019
Q1 | $4.9M | Buy |
25,777
+2,134
| +9% | +$408K | 0.29% | 84 |
|
|
2018
Q4 | $4.6M | Buy |
23,643
+11
| +0% | +$2.15K | 0.31% | 73 |
|
|
2018
Q3 | $4.9M | Sell |
23,632
-470
| -2% | -$92.6K | 0.29% | 76 |
|
|
2018
Q2 | $4.45M | Buy |
24,102
+1,919
| +9% | +$339K | 0.28% | 75 |
|
|
2018
Q1 | $3.78M | Buy |
22,183
+1,092
| +5% | +$200K | 0.25% | 84 |
|
|
2017
Q4 | $3.67M | Sell |
21,091
-929
| -4% | -$164K | 0.24% | 91 |
|
|
2017
Q3 | $4.11M | Sell |
22,020
-3,483
| -14% | -$617K | 0.28% | 83 |
|
|
2017
Q2 | $4.39M | Buy |
25,503
+3,172
| +14% | +$516K | 0.31% | 74 |
|
|
2017
Q1 | $3.66M | Buy |
22,331
+5,147
| +30% | +$855K | 0.28% | 82 |
|
|
2016
Q4 | $2.51M | Buy |
17,184
+13,207
| +332% | +$1.99M | 0.21% | 106 |
|
|
2016
Q3 | $663K | Buy |
3,977
+89
| +2% | +$15.1K | 0.06% | 235 |
|
|
2016
Q2 | $592K | Sell |
3,888
-156
| -4% | -$24.3K | 0.06% | 239 |
|
|
2016
Q1 | $606K | Sell |
4,044
-397
| -9% | -$59K | 0.06% | 228 |
|
|
2015
Q4 | $721K | Buy |
4,441
+82
| +2% | +$12.9K | 0.07% | 200 |
|
|
2015
Q3 | $603K | Buy |
4,359
+362
| +9% | +$57.1K | 0.07% | 210 |
|
|
2015
Q2 | $614K | Buy |
3,997
+162
| +4% | +$26K | 0.07% | 216 |
|
|
2015
Q1 | $613K | Sell |
3,835
-34
| -0.9% | -$5.36K | 0.06% | 221 |
|
|
2014
Q4 | $616K | Sell |
3,869
-19
| -0.5% | -$2.96K | 0.07% | 221 |
|
|
2014
Q3 | $546K | Sell |
3,888
-348
| -8% | -$45.4K | 0.06% | 218 |
|
|
2014
Q2 | $501K | Sell |
4,236
-222
| -5% | -$25.7K | 0.06% | 231 |
|
|
2014
Q1 | $550K | Buy |
4,458
+2
| +0% | +$243 | 0.07% | 224 |
|
|
2013
Q4 | $508K | Buy |
+4,456
| New | +$507K | 0.07% | 223 |
|
Other funds holding AMGN
VCM
VPM
Capital Investment Advisors's AMGN Position: Q1 2026 in Review
Capital Investment Advisors increased its Amgen (AMGN) stake by 2.4% in Q1 2026, buying an estimated $261K and bringing the position to 31,596 shares worth $11.1M. The position accounts for 0.16% of the portfolio, ranked #110.
Capital Investment Advisors first reported a position in AMGN in Q4 2013 and has held it in 50 quarters since. The position peaked at $15.8M in Q2 2020. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Capital Investment Advisors held 31,596 shares of Amgen worth $11.1M as of Q1 2026.
- Capital Investment Advisors bought 732 Amgen shares in Q1 2026, an estimated $261K.
- Amgen made up 0.16% of Capital Investment Advisors's portfolio in Q1 2026, its #110 holding.
- Capital Investment Advisors first reported a position in Amgen in Q4 2013 and has held it in 50 quarters since.
- Capital Investment Advisors's Amgen position peaked at $15.8M in Q2 2020.
- 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Capital Investment Advisors's 13F filing for Q1 2026, filed 16 Apr 2026.